Marked Weight Loss, Muscle Wasting and Fatigue on Administration of Empagliflozin in a Subject with Type 2 Diabetes

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2017, Vol 21, Issue 5

Abstract

Background: Weight loss, fatigue and decreased quality of life are frequently reported at the time of initial diagnosis by subjects with Diabetes Mellitus of both types although far more frequently with type 1 and are attributed to fluid and electrolyte losses due to persistent glycosuria as well as decline in adipose tissue secondary to lipolysis. However, muscle wasting and weakness as initial manifestations are noted almost exclusively in subjects with type 1 diabetes. Case Report: A man with history of type 2 diabetes about 10 years reported onset of general fatigue, polyuria, nocturia, polydipsia as well as profound progressive weight loss, muscle wasting and weakness within 2 weeks after initiation of Empagliflozin. He had been receiving glimepiride 8 mg and metformin 2000 mg daily for about 5.5 years. Resolution of polyuria, nocturia and polydipsia was attained promptly within a week after discontinuation of Empagliflozin and initiation of insulin glargine. Weight gain and improvement in fatigue began by 2 weeks, continued until achieving desirable glycemic control over next 4 months and then stabilized. However, muscle mass and strength have not yet returned to the level prior to initiation of Empagliflozin during the follow up period of 12 months. Conclusion: Empagliflozin is responsible for induction of transient weight loss as well as persistent muscle weakness and wasting in this subject.

Authors and Affiliations

Udaya M. Kabadi

Keywords

Related Articles

Evaluation of Preventive Self-care Behaviors and Its Related Factors in Patients with Heart Failure

Background: Self-care behaviors are the most important way to prevent frequent hospitalization, improve the quality of life, and reduce mortality in patients suffering from heart failure. Aims: To assess the preventive s...

Control of Measles in Nigeria: A Critical Review of the Literature

The Millennium Development Goals identify the health and wellbeing of children as important indices of meaningful development. An important aspect of child survival is the control of vaccine-preventable diseases. Measles...

Estimated Glomerular Filtration Rate in Patients with Lower Urinary Tract Symptoms/Benign Prostatic Obstruction in an Emerging Tertiary Centre

Background: The association of benign prostatic hypertrophy (BPH) and chronic kidney disease (CKD) has been a subject of controversies. Combinations of recurrent urinary tract infections, chronic retention with large res...

Breast Cancer in Muslim Countries: Risk Reduction Strategies

Breast cancer is the most common cancer in women in western countries and is becoming significant in many developing countries. It is the most common cancer and the primary cause of cancer-related mortality in women in M...

Investigation of Gender Difference of Physiological Response in Gonadectomy in Sprague-Dawley (SD) Rats

Aim: Sex hormones, including testosterone and estrogen, result in various pathophysiological changes in the body. To evaluate the pathophysiological changes following gonadectomy in male and female rats, we performed gon...

Download PDF file
  • EP ID EP311728
  • DOI 10.9734/BJMMR/2017/33253
  • Views 76
  • Downloads 0

How To Cite

Udaya M. Kabadi (2017). Marked Weight Loss, Muscle Wasting and Fatigue on Administration of Empagliflozin in a Subject with Type 2 Diabetes. Journal of Advances in Medicine and Medical Research, 21(5), 1-7. https://www.europub.co.uk/articles/-A-311728